Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Driving ability in adults with ADHD before and after 10 weeks of atomoxetine treatment compared with untreated adults with ADHD
2007-004309-90Phase 3Active
- Sponsor
- Central Institute of Mental Health
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of atomoxetine in attention deficit hyperactivity disorder (ADHD) (2 arms), sponsored by Central Institute of Mental Health. Started Aug 2007; status: active.
02
Drugs
atomoxetine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2007-004309-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004309-90.